Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2668 of 3330
Next
>>
>
66676 to 66700 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
HCC202	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	7841.068	0.6310	-0.0217	0.6440
HCC202	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7841.068	0.5568	-0.1944	0.6440
HCC202	HER2amp	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7841.068	0.5730	-0.1577	0.6440
HCC202	HER2amp	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7841.068	0.5621	-0.1824	0.6440
HCC202	HER2amp	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7841.068	0.3851	-0.5456	0.6440
HCC202	HER2amp	Luminal	Sirolimus	MTOR	MTOR	167	uM	7841.068	0.0089	-0.9987	0.6440
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	7463.068	0.8261	0.4456	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	7463.068	0.7864	0.3297	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	7463.068	0.7397	0.1983	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	7463.068	0.7026	0.0982	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7463.068	0.6992	0.0891	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7463.068	0.7164	0.1349	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7463.068	0.7349	0.1852	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7463.068	0.6390	-0.0655	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	167	uM	7463.068	0.6582	-0.0172	0.5887
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.0000853	uM	7464.069	0.9757	0.9256	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	7464.069	0.9780	0.9328	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	7464.069	0.7614	0.3145	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	7464.069	0.6248	-0.0305	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	7464.069	0.6678	0.0740	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7464.069	0.6567	0.0468	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7464.069	0.6726	0.0861	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7464.069	0.6451	0.0184	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7464.069	0.5767	-0.1430	0.6495
HCC2185	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	7845.068	0.9388	0.6976	0.3849

|<
<<
Previous
Page 2668 of 3330
Next
>>
>
66676 to 66700 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)